Skip to main content
Top
Published in: Critical Care 3/2003

01-06-2004 | Commentary

How to compare adequacy of algorithms to control blood glucose in the intensive care unit?

Author: Greet Van den Berghe

Published in: Critical Care | Issue 3/2003

Login to get access

Abstract

Vogelzang et al. retrospectively assessed a derivative marker of blood glucose control over time in the intensive care unit (ICU), "the hyperglycemic index" (HGI), in relation to outcome. The HGI predicted mortality better than other indices of blood glucose control that do not take the duration of hyperglycemia into account. This provided further support to the concept of maintaining normoglycemia with insulin throughout intensive care in order to improve outcome. The HGI was also proposed as a tool to assess performance of glucose control algorithms. This, however, implies similar sampling frequency for the compared algorithms. Just as we prefer continuous, online display of blood pressure and/or cardiac output for optimal titration of inotropes and vasopressors, a continuous display of blood glucose levels is mandatory for optimal titration of insulin therapy in ICU. We anxiously await the development and validation of such devices.
Literature
1.
go back to reference Vogelzang M, van der Horst ICC, Nijsten MWN: Hyperglycaemic index as a tool to assess glucose control: a retrospective study. Crit Care 2004, 8: R122-R127. 10.1186/cc2840PubMedCentralCrossRefPubMed Vogelzang M, van der Horst ICC, Nijsten MWN: Hyperglycaemic index as a tool to assess glucose control: a retrospective study. Crit Care 2004, 8: R122-R127. 10.1186/cc2840PubMedCentralCrossRefPubMed
2.
go back to reference Baird TA, Parsons MW, Phanh T, Butcher KS, Desmond PM, Tress BM, Colman PG, Chambers BR, Davis SM: Persistent poststroke heperglycemia is independently associated with infarct expansion and worse clinical outcome. Stroke 2003, 34: 2208-2214. 10.1161/01.STR.0000085087.41330.FFCrossRefPubMed Baird TA, Parsons MW, Phanh T, Butcher KS, Desmond PM, Tress BM, Colman PG, Chambers BR, Davis SM: Persistent poststroke heperglycemia is independently associated with infarct expansion and worse clinical outcome. Stroke 2003, 34: 2208-2214. 10.1161/01.STR.0000085087.41330.FFCrossRefPubMed
3.
go back to reference Finney SJ, Zekveld C, Elia A, Evans TW: Glucose control and mortality in critically ill patients. JAMA 2003, 290: 2041-2047. 10.1001/jama.290.15.2041CrossRefPubMed Finney SJ, Zekveld C, Elia A, Evans TW: Glucose control and mortality in critically ill patients. JAMA 2003, 290: 2041-2047. 10.1001/jama.290.15.2041CrossRefPubMed
4.
go back to reference Krinsley JS: Association between hyperglycemia and increased hospital mortality in a heterogenous population of critically ill patients. Mayo Clin Proc 2003, 78: 1471-1478.CrossRefPubMed Krinsley JS: Association between hyperglycemia and increased hospital mortality in a heterogenous population of critically ill patients. Mayo Clin Proc 2003, 78: 1471-1478.CrossRefPubMed
5.
go back to reference Capes SE, Hunt D, Malmberg K, Gerstein HC: Stress hyperglycemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systemaic overview. Lancet 2000, 355: 773-778. 10.1016/S0140-6736(99)08415-9CrossRefPubMed Capes SE, Hunt D, Malmberg K, Gerstein HC: Stress hyperglycemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systemaic overview. Lancet 2000, 355: 773-778. 10.1016/S0140-6736(99)08415-9CrossRefPubMed
6.
go back to reference Mesotten D, Delhanty PJD, Vanderhoydonc F, Hardman KV, Weekers F, Baxter RC, Van den Berghe G: Regulation of insulin-like growth factor binding protein-1 during protracted critical illness. J Clin Endocrinol Metab 2002, 87: 5516-5523. 10.1210/jc.2002-020664CrossRefPubMed Mesotten D, Delhanty PJD, Vanderhoydonc F, Hardman KV, Weekers F, Baxter RC, Van den Berghe G: Regulation of insulin-like growth factor binding protein-1 during protracted critical illness. J Clin Endocrinol Metab 2002, 87: 5516-5523. 10.1210/jc.2002-020664CrossRefPubMed
7.
go back to reference Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R: Intensive insulin therapy in critically ill patients. N Engl J Med 2001, 345: 1359-1367. 10.1056/NEJMoa011300CrossRefPubMed Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R: Intensive insulin therapy in critically ill patients. N Engl J Med 2001, 345: 1359-1367. 10.1056/NEJMoa011300CrossRefPubMed
8.
go back to reference Van den Berghe G, Wouters PJ, Bouillon R, Weekers F, Verwaest C, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P: Outcome benefit of intensive insulin therapy in the critically ill : insulin dose versus glycemic control. Crit Care Med 2003, 31: 359-366. 10.1097/01.CCM.0000045568.12881.10CrossRefPubMed Van den Berghe G, Wouters PJ, Bouillon R, Weekers F, Verwaest C, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P: Outcome benefit of intensive insulin therapy in the critically ill : insulin dose versus glycemic control. Crit Care Med 2003, 31: 359-366. 10.1097/01.CCM.0000045568.12881.10CrossRefPubMed
Metadata
Title
How to compare adequacy of algorithms to control blood glucose in the intensive care unit?
Author
Greet Van den Berghe
Publication date
01-06-2004
Publisher
BioMed Central
Published in
Critical Care / Issue 3/2003
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/cc2856

Other articles of this Issue 3/2003

Critical Care 3/2003 Go to the issue